about
Intranasal corticosteroids for non-allergic rhinitisRhinitis in the geriatric population.Topical beclomethasone in the therapy of smelling disorders-a new application techniqueChoosing wisely: practical considerations on treatment efficacy and safety of asthma in the elderly.The effects of topical nasal steroids on continuous positive airway pressure compliance in patients with obstructive sleep apnea: a systematic review and meta-analysis.The effect of long-term use of intranasal steroids on intraocular pressure.Treatment of chronic rhinosinusitis with pressure-pulsed corticosteroid inhalation.Diagnosis and management of nasal congestion: the role of intranasal corticosteroids.Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis.Topical intranasal corticosteroids and growth velocity in children: a meta-analysis.Current understanding of nasal morphology and physiology as a drug delivery target.Intranasal Steroid Use for Otitis Media with Effusion: Ongoing Opportunities for Quality Improvement.[Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application].Risk of nasal septal perforation following septoplasty in patients with allergic rhinitis.Examining the safety of prednisolone acetate 1% nasal spray for treatment of nasal polyposis.Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis.The safety and efficacy of short-term budesonide delivered via mucosal atomization device for chronic rhinosinusitis without nasal polyposis.Comparison of delivery of topical medications to the paranasal sinuses via "vertex-to-floor" position and atomizer spray after FESS.
P2860
Q24202371-9E51425A-C78B-4E43-AC38-BAED77F977CFQ30481057-358DBF2E-1DDF-4954-BB97-1312C8C94EDDQ35030703-4690071A-AFC6-42E0-A6C1-7496C45EFD99Q35765263-D25F408D-4DBC-4AAE-A4BB-C5249945EE2EQ36071841-63AB3545-9475-4B98-A482-45DBD4EC5DFDQ37012191-0CED65C6-DB81-453A-A0E5-8BDA12629F56Q37083374-5E16FE79-E3BC-4664-85F9-EE2619171011Q37380516-833EE1A4-DF53-4E48-90C5-97076C7AC8ABQ37593588-39807D41-6B27-42F6-8434-AD4E58B1693AQ38264790-D2C850C4-7E5F-4D3E-98ED-C29BBF44F216Q38383290-CED5C6F0-D5A0-45A8-BB5C-05E7B4D8750EQ38769045-D652469B-EAFF-4F25-B1D7-49FDA080D0DAQ39248689-B12E45B2-D909-4BB9-88EF-A275553B80A5Q45128594-F098207F-B4F2-4C9E-BC37-F2B3B3049394Q46418057-6C78F6C8-CE83-418D-87E2-29AEE19D9A7CQ46514216-E9297E66-4741-401C-91F2-1A02C6765456Q48092547-23A60652-0066-432E-BA33-B90AC7A3247CQ51324418-F09DAADD-EC3C-4BE6-B548-947965AA1534
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The safety of intranasal steroids.
@ast
The safety of intranasal steroids.
@en
type
label
The safety of intranasal steroids.
@ast
The safety of intranasal steroids.
@en
prefLabel
The safety of intranasal steroids.
@ast
The safety of intranasal steroids.
@en
P1476
The safety of intranasal steroids.
@en
P2093
Michael S Benninger
Nadir Ahmad
P304
P356
10.1016/J.OTOHNS.2003.10.001
P577
2003-12-01T00:00:00Z